Recent advances of LSD1/KDM1A inhibitors for disease therapy
- 24 February 2023
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 134, 106443
Abstract
No abstract availableKeywords
Funding Information
- Science and Technology Innovation Talents in Universities of Henan Province (21HASTIT045)
- National Natural Science Foundation of China
- Natural Science Foundation of Henan Province (222300420069, 222301420049)
This publication has 73 references indexed in Scilit:
- Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved PharmaceuticalsJournal of Medicinal Chemistry, 2014
- 3,5-Diamino-1,2,4-triazoles as a novel scaffold for potent, reversible LSD1 (KDM1A) inhibitorsMedChemComm, 2014
- Recent advances in the synthesis of quinolines: a reviewRSC Advances, 2014
- Review on Natural Coumarin Lead Compounds for Their Pharmacological ActivityBioMed Research International, 2013
- Histone methylation: a dynamic mark in health, disease and inheritanceNature Reviews Genetics, 2012
- Biochemical, Structural, and Biological Evaluation of Tranylcypromine Derivatives as Inhibitors of Histone Demethylases LSD1 and LSD2Journal of the American Chemical Society, 2010
- LSD1: oxidative chemistry for multifaceted functions in chromatin regulationTrends in Biochemical Sciences, 2008
- Crystal structure and mechanism of human lysine-specific demethylase-1Nature Structural & Molecular Biology, 2006
- Histone H3 Lysine 4 Demethylation Is a Target of Nonselective Antidepressive MedicationsChemistry & Biology, 2006
- Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1Cell, 2004